METHOD AND PHARMACEUTICAL COMPOSITION FOR INHIBITI

专利名称：METHOD AND PHARMACEUTICAL

COMPOSITION FOR INHIBITINGPI3K/AKT/MTOR SIGNALING PATHWAY

发明人：Lei Duan,Victor Levenson,Guoguang Ying申请号：US14431441申请日：20130929

公开号：US20150328197A1公开日：20151119

摘要：The present invention relates to a pharmaceutical composition of PRCPantagonist, PREP antagonist, or PRCP-PREP dual antagonist. The present invention alsorelates to a pharmaceutical composition jointly using PRCP antagonist and mTORantagonist, or jointly using PREP antagonist and mTOR antagonist, or jointly using PRCP-PREP dual antagonist and mTOR antagonist. In addition, the present invention alsorelates to a method for utilizing the pharmaceutical compositions to treat and preventcancers and diseases related to insulin receptor substrate protein and PI3K/AKT/mTORsignal pathway.

申请人：Targeted Therapeutics, LLC

地址：Buffallo Grove IL US

国籍：US

更多信息请下载全文后查看